Glaucoma. Glaucoma
Conditions
Interventions
Intervention 1: Intervention group: pre-treatment with betamethasone eye drop 1% from 3 days before surgery until the time of surgery, 6 times a day in patients candidate for insertion of Ahmed valve
Sponsors
Basir eye health research center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with no age limit with IOPs less than target pressure in whom glaucoma drainage implant (GDI) surgery was planned were enrolled in the study
Exclusion criteria
Exclusion criteria: Exclusion criteria were no light perception at baseline history of ocular surface infection in recent two weeks pregnancy breast feeding lack of healthy conjunctiva for AGV insertion sensitivity to betamethasone eye drop
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Goldman applanation tonometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of eyes requiring medications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Quantitative.;Number of medications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Quantitative.;Best corrected visual acuity (BCVA). Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: tumbling E-chart.;Complications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: qualitative. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Yadegari
Basir eye health research center
Outcome results
None listed